Miriam Komaromy

Dr. Miriam Komaromy specializes in the field of medicine with a focus on addressing health disparities and improving care for underserved populations. As a Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, she brings a wealth of knowledge and experience to her role. In addition to her academic responsibilities, Dr. Komaromy serves as the Medical Director of the Grayken Center for Addiction at Boston Medical Center, where she plays a pivotal role in shaping the future of addiction treatment and research. Her research interests are deeply rooted in medical education, substance use disorders, and the health challenges faced by marginalized populations. Dr. Komaromy is dedicated to developing innovative models of post-graduate medical education that equip healthcare professionals with the skills needed to address complex health conditions. Her work is particularly focused on expanding access to care and ensuring that patients with substance use disorders receive the support and treatment they need. Dr. Komaromy's commitment to her field has been recognized through numerous accolades. She has been honored with the ASAM Educator of the Year Award, highlighting her contributions to medical education and her impact on the field of addiction medicine. Additionally, she was awarded a Fulbright Scholar award by the US State Department, further underscoring her dedication to advancing healthcare on a global scale. Throughout her career, Dr. Komaromy has been a strong advocate for marginalized populations, working tirelessly to address the health disparities that affect these communities. Her efforts have not only improved the lives of countless individuals but have also contributed to a broader understanding of the challenges faced by underserved populations in accessing healthcare. Dr. Komaromy's work continues to inspire and influence the next generation of healthcare professionals. Her dedication to improving healthcare outcomes for all, particularly those most in need, remains at the forefront of her professional endeavors. Her leadership and vision are instrumental in driving forward the mission of the Grayken Center for Addiction and the broader medical community.